Cargando…

Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study

BACKGROUND AND OBJECTIVES: Hypersensitivity pneumonitis (HP) is a rare disease, which can lead to premature death. Few studies have investigated HP on a national level. The objective of this study was to investigate incidence, survival rate, and comorbidity of HP in Denmark. METHODS: Using the Danis...

Descripción completa

Detalles Bibliográficos
Autores principales: Rittig, Anne Hald, Hilberg, Ole, Ibsen, Rikke, Løkke, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801213/
https://www.ncbi.nlm.nih.gov/pubmed/31649947
http://dx.doi.org/10.1183/23120541.00259-2018
_version_ 1783460536195743744
author Rittig, Anne Hald
Hilberg, Ole
Ibsen, Rikke
Løkke, Anders
author_facet Rittig, Anne Hald
Hilberg, Ole
Ibsen, Rikke
Løkke, Anders
author_sort Rittig, Anne Hald
collection PubMed
description BACKGROUND AND OBJECTIVES: Hypersensitivity pneumonitis (HP) is a rare disease, which can lead to premature death. Few studies have investigated HP on a national level. The objective of this study was to investigate incidence, survival rate, and comorbidity of HP in Denmark. METHODS: Using the Danish National Patient Registry we identified all patients with a first-time diagnosis of HP between 1998 and 2010. Patients with HP were matched 1:4 with controls by sex, age and geography in this case-control study. Comorbidity 3 years prior to diagnosis was explored by the Charlson score index. Survival rates were assessed using Kaplan–Meier curves and hazard ratios. RESULTS: We identified 753 patients during the observation period equalling an average HP incidence of 1.16 per 100 000 citizens. Patients with HP had a significantly higher Charlson score index when compared with the matched controls and an increased risk of dying (hazard ratio 1.98, CI 1.61–2.58, se 0.14, p<0.001). Survival rates of HP were lower at all time points when compared with the matched control population. The decline in survival was observed for both male and female patients with HP with no clear sex difference. Most deaths were related to diseases of the heart and lungs. CONCLUSIONS: In this Danish longitudinal nationwide observational study we found an increased Charlson score index combined with a higher mortality without sex difference among patients with HP compared with a healthy control group, mainly due to diseases of the heart and lungs.
format Online
Article
Text
id pubmed-6801213
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Respiratory Society
record_format MEDLINE/PubMed
spelling pubmed-68012132019-10-24 Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study Rittig, Anne Hald Hilberg, Ole Ibsen, Rikke Løkke, Anders ERJ Open Res Original Articles BACKGROUND AND OBJECTIVES: Hypersensitivity pneumonitis (HP) is a rare disease, which can lead to premature death. Few studies have investigated HP on a national level. The objective of this study was to investigate incidence, survival rate, and comorbidity of HP in Denmark. METHODS: Using the Danish National Patient Registry we identified all patients with a first-time diagnosis of HP between 1998 and 2010. Patients with HP were matched 1:4 with controls by sex, age and geography in this case-control study. Comorbidity 3 years prior to diagnosis was explored by the Charlson score index. Survival rates were assessed using Kaplan–Meier curves and hazard ratios. RESULTS: We identified 753 patients during the observation period equalling an average HP incidence of 1.16 per 100 000 citizens. Patients with HP had a significantly higher Charlson score index when compared with the matched controls and an increased risk of dying (hazard ratio 1.98, CI 1.61–2.58, se 0.14, p<0.001). Survival rates of HP were lower at all time points when compared with the matched control population. The decline in survival was observed for both male and female patients with HP with no clear sex difference. Most deaths were related to diseases of the heart and lungs. CONCLUSIONS: In this Danish longitudinal nationwide observational study we found an increased Charlson score index combined with a higher mortality without sex difference among patients with HP compared with a healthy control group, mainly due to diseases of the heart and lungs. European Respiratory Society 2019-10-21 /pmc/articles/PMC6801213/ /pubmed/31649947 http://dx.doi.org/10.1183/23120541.00259-2018 Text en Copyright ©ERS 2019 http://creativecommons.org/licenses/by-nc/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
spellingShingle Original Articles
Rittig, Anne Hald
Hilberg, Ole
Ibsen, Rikke
Løkke, Anders
Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
title Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
title_full Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
title_fullStr Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
title_full_unstemmed Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
title_short Incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
title_sort incidence, comorbidity and survival rate of hypersensitivity pneumonitis: a national population-based study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801213/
https://www.ncbi.nlm.nih.gov/pubmed/31649947
http://dx.doi.org/10.1183/23120541.00259-2018
work_keys_str_mv AT rittigannehald incidencecomorbidityandsurvivalrateofhypersensitivitypneumonitisanationalpopulationbasedstudy
AT hilbergole incidencecomorbidityandsurvivalrateofhypersensitivitypneumonitisanationalpopulationbasedstudy
AT ibsenrikke incidencecomorbidityandsurvivalrateofhypersensitivitypneumonitisanationalpopulationbasedstudy
AT løkkeanders incidencecomorbidityandsurvivalrateofhypersensitivitypneumonitisanationalpopulationbasedstudy